AR099080A1 - Variantes de región fc con propiedades de unión a fcrn (receptor fc neonatal) modificadas y de unión a proteína a mantenidas - Google Patents
Variantes de región fc con propiedades de unión a fcrn (receptor fc neonatal) modificadas y de unión a proteína a mantenidasInfo
- Publication number
- AR099080A1 AR099080A1 ARP150100076A ARP150100076A AR099080A1 AR 099080 A1 AR099080 A1 AR 099080A1 AR P150100076 A ARP150100076 A AR P150100076A AR P150100076 A ARP150100076 A AR P150100076A AR 099080 A1 AR099080 A1 AR 099080A1
- Authority
- AR
- Argentina
- Prior art keywords
- union
- fcrn
- neonatal
- receiver
- maintained
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/524—CH2 domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/526—CH3 domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/53—Hinge
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/71—Decreased effector function due to an Fc-modification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
En el presente documento se comunica un polipéptido que comprende un primer polipéptido y un segundo polipéptido que comprende en dirección de N-terminal a C-terminal al menos una porción de una región bisagra de inmunoglobulina, que comprende uno o más restos de cisteína, un dominio CH2 de inmunoglobulina y un dominio CH3 de inmunoglobulina, en el que i) el primer polipéptido comprende las mutaciones I253A, H310A y H435A y el segundo polipéptido comprende las mutaciones H310A, H433A y Y436A, o ii) el primer polipéptido comprende las mutaciones I253A, H310A y H435A y el segundo polipéptido comprende las mutaciones L251D, L314D y L432D, o iii) el primer polipéptido comprende las mutaciones I253A, H310A y H435A y el segundo polipéptido comprende las mutaciones L251S, L314S y L432S. Formulación farmacéutica; uso.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14151320 | 2014-01-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR099080A1 true AR099080A1 (es) | 2016-06-29 |
Family
ID=49918650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150100076A AR099080A1 (es) | 2014-01-15 | 2015-01-13 | Variantes de región fc con propiedades de unión a fcrn (receptor fc neonatal) modificadas y de unión a proteína a mantenidas |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR099080A1 (es) |
-
2015
- 2015-01-13 AR ARP150100076A patent/AR099080A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016008539A (es) | Variantes de region fc con propiedades de union a receptor fc neonatal (fcrn) modificadas y de union a proteina a mantenidas. | |
| MX2016008540A (es) | Variantes de region fc con propiedades de union al receptor fc neonatal (fcrn). | |
| CL2018000269A1 (es) | Constructos de anticuerpo para flt3 y cd3 | |
| MX2016008782A (es) | Variantes de region fc con union mejorada de la proteina a. | |
| ECSP17073650A (es) | Proteínas de fusión | |
| MX2020010061A (es) | Variantes de region fc con union del receptor fc neonatal (fcrn) modificado y metodos de uso. | |
| PE20170503A1 (es) | Proteinas de fusion de interleucina 2/receptor de interleucina-2 alfa y metodos de uso | |
| CL2018000270A1 (es) | Constructos de anticuerpo para cd70 y cd3. | |
| CL2019001000A1 (es) | Proteínas de fusión fc heterodiméricas il15/il15ralfa | |
| EP3733716A4 (en) | DIMERAL FUSION PROTEIN USING ANTIBODY FC REGION AS A SKELETON AND ASSOCIATED USE | |
| BR112019014986A2 (pt) | anticorpo que alveja bcma e uso do mesmo | |
| PE20211272A1 (es) | POLIPEPTIDOS DE IL-22 Y PROTEINAS DE FUSION DE IL-22 Fc Y METODOS DE USO | |
| CL2016000232A1 (es) | Estabilización de polipéptidos que contienen fragmentos cristalizables | |
| BR112018015670A2 (pt) | construtos de anticorpo biespecíficos envolvendo células t | |
| CL2017001070A1 (es) | Variantes de interferon a2b | |
| CO2018013104A2 (es) | Polipéptidos de fusión cd40l-fc y sus métodos de uso | |
| EA201591700A1 (ru) | Гибридные белки апелина и их применение | |
| BR112019023071A2 (pt) | proteínas de fusão do receptor tgf-beta do tipo ii e uso das mesmas | |
| BR112019008351A2 (pt) | imunoglobulinas e usos das mesmas | |
| UA117493C2 (uk) | Гібридна конструкція, що включає антигенсполучний фрагмент, специфічний до сироваткового альбуміну, й ефекторний компонент, та способи її одержання | |
| AR099080A1 (es) | Variantes de región fc con propiedades de unión a fcrn (receptor fc neonatal) modificadas y de unión a proteína a mantenidas | |
| CR20150477A (es) | Polipéptidos de il-22 y proteínas de fusión de il-22 fc y métodos de uso | |
| AR106146A1 (es) | Anticuerpos anti-tigit y métodos de uso | |
| AR090915A1 (es) | Proteina de fusion de proteina linfopoyetina estromal timica canina con la region fc de igg | |
| AR095528A1 (es) | Polipéptidos de interleucina-22 (il-22) y proteínas de fusión de il-22 con fragmento de cadena pesada fc (il-22 fc) y métodos de uso |